| 000 | 01670 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250518051109.0 | ||
| 264 | 0 | _c20191211 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a1471-2407 | ||
| 024 | 7 |
_a10.1186/s12885-019-5857-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMärkl, Bruno | |
| 245 | 0 | 0 |
_aImpact of uPA/PAI-1 and disseminated cytokeratin-positive cells in breast cancer. _h[electronic resource] |
| 260 |
_bBMC cancer _cJul 2019 |
||
| 300 |
_a692 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 |
_aBone Marrow _xpathology |
| 650 | 0 | 4 |
_aBreast Neoplasms _xmetabolism |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 |
_aKeratins _xmetabolism |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aNeoplastic Cells, Circulating _xmetabolism |
| 650 | 0 | 4 |
_aPlasminogen Activator Inhibitor 1 _xmetabolism |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xmetabolism |
| 700 | 1 | _aKazik, Martin | |
| 700 | 1 | _aHarbeck, Nadia | |
| 700 | 1 | _aJakubowicz, Elzbieta | |
| 700 | 1 | _aHoffmann, Reinhard | |
| 700 | 1 | _aJung, Thomas | |
| 700 | 1 | _aSteinfeld, Dieter | |
| 700 | 1 | _aSchenkirsch, Gerhard | |
| 700 | 1 | _aSchlimok, Günter | |
| 700 | 1 | _aOruzio, Daniel | |
| 773 | 0 |
_tBMC cancer _gvol. 19 _gno. 1 _gp. 692 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12885-019-5857-0 _zAvailable from publisher's website |
| 999 |
_c29902963 _d29902963 |
||